Omnibuds
Nashville, US · Founded 2025 · 1 known investors
Find your way into Omnibuds
Sign up to see every warm intro you have to Omnibuds
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Omnibuds team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
OmniBuds develops ear-worn biosensing earbuds that continuously monitor cardiovascular and physiological signals through AI-powered analysis. The platform serves researchers, clinicians, and health-conscious individuals seeking accessible, unobtrusive insight into their body's cardiovascular responses during daily life.
Founders & leadership
Omnibuds was founded in 2025 by Ben Carter, Fahim Kawsar, and Alessandro Montanari.
BC

Ben CarterCEO | Co-founderBen Carter co-founded OmniBuds, where he serves as CEO developing ear-worn biosensing technology for cardiovascular monitoring. Previously, he was CCO at B-Secur, where he led commercialization of FDA-cleared cardiac technology and held over 25 years of executive leadership roles in technology, telecommunications, and digital health across companies including Microsoft, Nokia, Samsung, Google, and Amazon.
FK

AM

Alessandro MontanariFounder & Chief Scientific OfficerAlessandro Montanari holds a PhD in Computer Science from the University of Cambridge and an MEng from the University of Bologna. He was a Principal Research Scientist at Nokia Bell Labs leading the Device Forms team, where he worked on wearable systems, ultra-low-power machine learning, and acoustic sensing, with prior experience at ABB Corporate Research, ARM, and the University of Cambridge.
BC
Benedict CarterNamed on SEC filing
JC
Joseph CaradonnaNamed on SEC filing
JK
Jeffrey KarrasNamed on SEC filing
JH
James HaywardNamed on SEC filing
CD
Chris D. JonesNamed on SEC filing
FK
Fahim KawsaarNamed on SEC filing
JS
James StefansicNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2026
▶$3MraisedOct 2026 · 2 investors · Other Health CareRule 506(b)
▶$3MraisedOct 2026 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Benedict CarterExecutive Officer, Director
- Joseph CaradonnaDirector
- Jeffrey KarrasDirector
- James HaywardDirector
- Chris D. JonesDirector
- Fahim KawsaarDirector
- James StefansicExecutive Officer
- Offering amount
- $14.6M
- Amount sold
- $3M
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Omnibuds do?
- OmniBuds develops ear-worn biosensing earbuds that continuously monitor cardiovascular and physiological signals through AI-powered analysis. The platform serves researchers, clinicians, and health-conscious individuals seeking accessible, unobtrusive insight into their body's cardiovascular responses during daily life.
- Who founded Omnibuds?
- Omnibuds was founded by Ben Carter, Fahim Kawsar, Alessandro Montanari in 2025.
- Who are Omnibuds's investors?
- Omnibuds's investors include America's Frontier Fund.
- How much funding has Omnibuds raised?
- Omnibuds has disclosed $3M raised across 1 round.
- Where is Omnibuds headquartered?
- Omnibuds is headquartered in Nashville, US.

